SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Maheshwari Anurag (Last) (First) (Middle) 1 CARRIER PLACE (Street) FARMINGTON CT 06032 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 08/12/2022	3. Issuer Name and Ticker or Trading Symbol Otis Worldwide Corp [ OTIS ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) EVP and CFO	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	10,127	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSUs)(1)	(2)	(1)	Common Stock	1,346	0(1)	D
Restricted Stock Units (RSUs)(1)	(3)	(1)	Common Stock	1,112	0(1)	D
Restricted Stock Units (RSUs)(1)	(4)	(1)	Common Stock	10,105	0(1)	D
Restricted Stock Units (RSUs)(1)	(5)	(1)	Common Stock	14,174	0(1)	D
Stock Appreciation Rights	(6)	02/02/2032	Common Stock	5,417	81.85	D
Stock Appreciation Rights	(7)	02/04/2031	Common Stock	7,214	63.93	D
Stock Appreciation Rights	(8)	05/10/2030	Common Stock	64,300	51.81	D

Explanation of Responses:

1. Restricted Stock Units (RSUs) convert into common stock on a one for one basis.

2. These RSUs, which accrue dividend equivalents, are scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. The date of grant was February 3, 2022.

3. These RSUs, which accrue dividend equivalents, are scheduled to vest in two equal annual installments on the second and third anniversaries of the date of grant. The date of grant was February 5, 2021.

4. These RSUs, which accrue dividend equivalents, are scheduled to vest in full on the third anniversary of the date of grant. The date of grant was June 1, 2020.

5. These RSUs, which accrue dividend equivalents, are scheduled to vest in full on the third anniversary of the date of grant. The date of grant was May 11, 2020.

6. These stock appreciation rights are scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. The date of grant was February 3, 2022.

7. These stock appreciation rights were granted on February 5, 2021. 2,404 vested on February 5,2022 and the remainder are scheduled to vest in two equal annual installments on the second and third anniversaries of the date of grant.

8. These stock appreciation rights were granted on May 11, 2020. 21,000 vested on May 11, 2022 and the remainder vest in full on the third anniversary of the date of grant.

	Joshua Mullin, Attorney-in-Fact	08/18/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

POWER OF ATTORNEY

Know all by these presents that the undersigned hereby constitutes
and appoints each of Nora LaFreniere, Toby Smith, Joshua Mullin,
Debra Guss and Caroline Coursant, signing individually, as the
undersigned's true and lawful attorney-in-fact to:

(1)	execute, for and on behalf of the undersigned, Forms 3, 4,
and 5 (and any replacement form or successor to such forms, as may
be established by the U.S. Securities and Exchange Commission from
time to time) in accordance with Section 16(a) of the Securities
Exchange Act of 1934, as amended from time to time and the rules
thereunder;

(2)	execute, for and on behalf of the undersigned, any Form
144 (and any replacement form or successor to such form, as may
be established by the U.S. Securities and Exchange Commission
from time to time) required to be filed on behalf of the
undersigned in accordance with Rule 144 of the U.S. Securities
and Exchange Commission, as amended from time to time;

(3)	do and perform any and all acts for and on behalf of
the undersigned which may be necessary or desirable to
complete and execute any of the documents referred to in items
(1) and (2) above and timely file the same with the U.S.
Securities and Exchange Commission and any stock exchange or
similar authority; and

(4)	take any action of any type whatsoever in connection
with the foregoing (including but not limited to the execution
of any written representations required on behalf of the
undersigned to confirm compliance with Rule 144) which, in the
opinion of such attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by, the undersigned, it
being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this
Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in
such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact
full power and authority to do and perform any and every act
and thing whatsoever requisite, necessary, or proper to be
done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with
full power of substitution or revocation, hereby ratifying
and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully
do or cause to be done by virtue of this power of attorney
and the rights and powers herein granted. The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not
assuming, nor is Otis Worldwide Corporation (the Company)
assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934, Rule
144 of the U.S. Securities and Exchange Commission or any
other provision of the securities laws.

This Power of Attorney shall come into in full force and
effect on August 12, 2022 and shall remain in effect until
the undersigned is no longer required to file any of the
documents referred to above with respect to the
undersigned's holdings of and transactions in securities
issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to the foregoing
attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 21st day of July, 2022.

Signed:  /s/ Anurag Maheshwari
	 Anurag Maheshwari